Literature DB >> 8968730

Differential distribution of endothelin peptides and receptors in human adrenal gland.

A P Davenport1, S L Hoskins, R E Kuc, C Plumpton.   

Abstract

Sub-type selective ligands revealed a differential distribution of endothelin (ET) receptors within human adrenal glands. High densities of ETA receptors were localized, using [125I]-PD151242, to the smooth muscle layer of the arteries, smaller vessels within the capsular plexus and to the secretory cells of zona glomerulosa (KD = 139.8 +/- 39.7, Bmax = 69.7 +/- 9.1 fmol mg-1 protein, mean of 3 individuals+/-sem). ETB receptors were present in the medulla (KD = 145.2 +/- 16.4, Bmax = 75.5 +/- 12.3), zona glomerulosa (KD = 100.6 +/- 35.1, Bmax = 63.1 +/- 10.0), fasiculata (KD 145.1 +/- 16.2, Bmax = 67.9 +/- 6.9) and reticularis (KD = 118.2 +/- 18.6, Bmax = 71.9 +/- 6.5). ETB receptors were not detected within the smooth muscle of the vasculature. Messenger RNA encoding both sub-types was present in adrenals. ET-like immunoreactivity was localized to the cytoplasm of the endothelial cells from arteries supplying the gland and resistance vessels within the capsular plexus. Staining was also detected in these cells using anti-big ET-1 and less intensely with anti-big ET-2 antisera but not within cells within the cortex or medulla. Big ET-3-like immunoreactivity was localized to secretory cells of the medulla. Staining was not found using antiserum that could detect ET-3, suggesting further processing of big ET-3 may occur within the plasma, and that the adrenals could be a source of ET-3. The presence of ET-1 was confirmed by high performance liquid chromatography and radioimmunoassay although ET-3 was not detected. The results suggest that ET-1 is the predominant mature isoform, which is localized mainly to adrenal vasculature, particularly the capsular plexus, and may contribute to blood flow regulation in the gland.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968730     DOI: 10.1007/bf02272151

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  34 in total

1.  Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue.

Authors:  P G Howard; C Plumpton; A P Davenport
Journal:  J Hypertens       Date:  1992-11       Impact factor: 4.844

2.  Expression of endothelin peptides and mRNA in the human heart.

Authors:  C Plumpton; M J Ashby; R E Kuc; G O'Reilly; A P Davenport
Journal:  Clin Sci (Lond)       Date:  1996-01       Impact factor: 6.124

3.  Cloning and chromosomal localization of a human endothelin ETA receptor.

Authors:  C Cyr; K Huebner; T Druck; R Kris
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

4.  Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.

Authors:  F E Karet; R E Kuc; A P Davenport
Journal:  Kidney Int       Date:  1993-07       Impact factor: 10.612

5.  ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

6.  The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells.

Authors:  J P Hinson; G P Vinson; S Kapas; R Teja
Journal:  J Endocrinol       Date:  1991-02       Impact factor: 4.286

7.  Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm.

Authors:  C Plumpton; W G Haynes; D J Webb; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide.

Authors:  S Gasic; O F Wagner; H Vierhapper; P Nowotny; W Waldhäusl
Journal:  J Cardiovasc Pharmacol       Date:  1992-02       Impact factor: 3.105

9.  Autoradiographic study of endothelin receptors in human cerebral arteries.

Authors:  L N Pierre; A P Davenport
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

10.  Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.

Authors:  G O'Reilly; D S Charnock-Jones; A P Davenport; I T Cameron; S K Smith
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

View more
  6 in total

1.  Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.

Authors:  Salvatore Valiante; Marina Prisco; Maria De Falco; Francesca Virgilio; Rosaria Sciarrillo; Piero Andreuccetti; Vincenza Laforgia; Lorenzo Varano
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.

Authors:  S D Katugampola; J J Maguire; S R Matthewson; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.

Authors:  J J Maguire; R E Kuc; A P Davenport
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  Generation and characterization of an endothelin-2 iCre mouse.

Authors:  Joseph A Cacioppo; Yongbum Koo; Po-Ching Patrick Lin; Arnon Gal; CheMyong Ko
Journal:  Genesis       Date:  2015-02-12       Impact factor: 2.487

Review 6.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.